Frontiers in Oncology (Jan 2022)
Commentary: Association of Sarcopenia with Toxicity and Survival in Postoperative Recurrent Esophageal Squamous Cell Carcinoma Patients Receiving Chemoradiotherapy
Abstract
No abstracts available.Keywords
Frontiers in Oncology (Jan 2022)